Fangyong Lei

575 total citations
10 papers, 354 citations indexed

About

Fangyong Lei is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fangyong Lei has authored 10 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fangyong Lei's work include MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (3 papers) and RNA modifications and cancer (2 papers). Fangyong Lei is often cited by papers focused on MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (3 papers) and RNA modifications and cancer (2 papers). Fangyong Lei collaborates with scholars based in China and Germany. Fangyong Lei's co-authors include Shu‐Biao Wu, Xin Zhang, Aibin Liu, Libing Song, Jinrong Zhu, Geyan Wu, Lili Jiang, Longjuan Zhang, Junling Liu and Lixue Cao and has published in prestigious journals such as PLoS ONE, Cancer Research and The Journal of Pathology.

In The Last Decade

Fangyong Lei

10 papers receiving 350 citations

Peers

Countries citing papers authored by Fangyong Lei

Since Specialization

Citations

This map shows the geographic impact of Fangyong Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangyong Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangyong Lei more than expected).

Fields of papers citing papers by Fangyong Lei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangyong Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangyong Lei. The network helps show where Fangyong Lei may publish in the future.

Co-authorship network of co-authors of Fangyong Lei

This figure shows the co-authorship network connecting the top 25 collaborators of Fangyong Lei. A scholar is included among the top collaborators of Fangyong Lei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangyong Lei. Fangyong Lei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	miR-892b Silencing Activates NF-κB and Promotes Aggressiveness in Breast Cancer 2016 ·Cancer Research ·Lili Jiang, Liang Yu, Xin Zhang, Fangyong Lei, Lan Wang, Xiangxia Liu, Shu‐Biao Wu, Jinrong Zhu, Geyan Wu, Lixue Cao, Aibin Liu, Libing Song, Jun Li	67
2	Prostate tumour overexpressed‐1 promotes tumourigenicity in human breast cancer via activation of Wnt/β‐catenin signalling 2016 ·The Journal of Pathology ·Yanmei Cui, Weifeng Ma, Fangyong Lei, Qingyuan Li, Yanhong Su, Xi Lin, Chuyong Lin, Xin Zhang, Liping Ye, Shu‐Biao Wu, Jun Li, Zhongyu Yuan, Libing Song	21
3	Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes 2015 ·PLoS ONE ·Qi Yang, Huan‐Xin Lin, Shu‐Biao Wu, Fangyong Lei, Xi Zhu, Libing Song, Ming‐Huang Hong, Ling Guo	16
4	Downregulated miR-495 Inhibits the G1-S Phase Transition by Targeting Bmi-1 in Breast Cancer 2015 ·Medicine ·Lan Wang, Junling Liu, (unknown), Xiangxia Liu, Hongmei Wu, Fangyong Lei, Shu‐Biao Wu, Xi Wang	30
5	C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer 2015 ·Tumor Biology ·Weijing Zhang, Jianping Ou, Fangyong Lei, Teng Hou, Shu‐Biao Wu, (unknown), Liqun Xu, Yanna Zhang	21
6	Overexpression of chromosome 14 open reading frame 166 correlates with disease progression and poorer prognosis in human NPC 2015 ·Tumor Biology ·(unknown), Feng-Yan Li, Fangyong Lei, Yan Wang, Shu‐Biao Wu, Libing Song, (unknown)	7
7	miR-93 Promotes Cell Proliferation in Gliomas through Activation of PI3K/Akt Signaling Pathway 2015 ·Oncotarget ·Lili Jiang, Chanjuan Wang, Fangyong Lei, Longjuan Zhang, Xin Zhang, Aibin Liu, Geyan Wu, Jinrong Zhu, Libing Song	89
8	MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway 2015 ·Oncotarget ·Geyan Wu, Aibin Liu, Jinrong Zhu, Fangyong Lei, Shu‐Biao Wu, Xin Zhang, Liping Ye, Lixue Cao, Shanyang He	46
9	MicroRNA-500 sustains nuclear factor-κB activation and induces gastric cancer cell proliferation and resistance to apoptosis 2015 ·Oncotarget ·Liang Zhang, Ya Ding, Zhongyu Yuan, Junling Liu, (unknown), Fangyong Lei, Shu‐Biao Wu, Li Su, Dongsheng Zhang	39
10	Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer 2014 ·BMC Cancer ·Fangyong Lei, Longjuan Zhang, Xinghua Li, Xi Lin, Shu‐Biao Wu, Feng‐Yan Li, Junling Liu	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact